Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soy husk powder extract is a natural product derived from the outer fibrous covering of soybeans (Glycine max), which is a significant by-product of the soybean processing industry. This extract is rich in various bioactive compounds, including phenolics, polysaccharides, and other phytochemicals. Research indicates its potential as a nutraceutical, demonstrating beneficial effects on physical and biochemical parameters associated with obesity and diabetes, partly through the upregulation of Peroxisome proliferator-activated receptor gamma (PPARγ) expression. Additionally, it exhibits antioxidant properties by scavenging free radicals, immunostimulatory activity on macrophages, and hepatoprotective effects. Components like soy isoflavones, often present in broader soy extracts, are recognized for their contributions to cardiovascular health, bone density, and alleviation of menopausal symptoms. Soy oligosaccharides can also promote beneficial gut bacteria, improving microbial balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on soy husk powder extract.